Verein Zur Praevention Und Therapie Boesartiger Erkrankungen Austrian Breast And Colorectal Cancer Study Group

The sponsor supports clinical research in early invasive triple-negative breast cancer with homologous recombination deficiency and in endocrine-responsive HER2-negative breast cancer, with a focus on pre-operative treatment strategies and surgical outcome assessment.

• Triple-negative breast cancer
• Homologous recombination deficiency
• HER2-negative early breast cancer
• Endocrine-responsive disease

Research activity in this area includes approaches aimed at improving response before surgery and refining treatment selection for biologically defined breast cancer subtypes.